Clinical Trial

Evaluatıon of TREM-1, MMP-8 and TIMP-1 Levels in Perı-Implant Crevicular Fluıd of Perı-Implanted Indıvıduals

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study was to evaluate the relationship between Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1), Matrix Metalloproteinases-8 (MMP-8) and Tissue Inhibitors of Metalloproteinases-1 (TIMP-1) levels in peri-implant crevicular fluid (PICF) in peri-implantitis patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-25.
Trial Details
NCT Number NCT07379892
Lead Sponsor Aydin Adnan Menderes University
Conditions Periimplantitis
Enrollment 54 participants
Start Date 2023-06-01
Primary Completion 2023-12-15 (estimated)
Study Completion 2024-05-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-09